Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 Billion in 2024 and is predicted to reach 4.4 Billion by the year 2034 at a 11.9 % CAGR during the forecast period for 2025-2034.
Global Cell and Gene Therapy Supply Chain/Logistics provides customizable services to support any stage of the supply chain, from the point of patient identification through cell harvest, therapeutic intervention, and long-term outcomes data collection. Cell and gene therapies are spearheading a new era in medicine, offering treatments specifically designed to target individual patients' needs. As therapies become more personalized, the need for robust and adaptable supply chain services is skyrocketing. From the procurement of patient-specific materials to the delivery of customized treatments, supply chain services are adapting to ensure seamless coordination of these complex processes. Providing personalized therapeutics along with smart packaging is a key challenge in this market.
1. Marken, a UPS Company
2. World Courier, a Cencora Company
3. DHL Global Forwarding / DHL Life Sciences & Healthcare
4. Kuehne + Nagel International AG (QuickSTAT)
5. Cryoport Systems, Inc.
6. UPS Healthcare (United Parcel Service, Inc.)
7. FedEx Express / FedEx Healthcare
8. Vineti, Inc.
9. TrakCel Ltd.
10. SAP SE
The challenges and needs of cell and gene therapy supply chains increase the need for more advanced IT systems. Most pharmaceutical companies are collaborating with IT companies to make services automated and less complex. Modern technology platforms for supply chain data management can help you control, manage, and monitor your supply chains in just a few clicks. For instance, Marken is developing technologies designed to address complex logistics and provide optimal supply chain solutions for the fast-growing cell and gene therapies market. The constant improvements in the cell and gene therapy (CGT) supply chain management services are expected to propel the Cell and Gene Therapy Supply Chain/Logistics market growth over the forecast period.
The increasing need for cell and gene therapies, developments in the real-time supply chain operations, and the rising number of clinical trials is likely to evolve the Cell and Gene Therapy Supply Chain/Logistics market at a considerable rate in the next few years. Furthermore, advanced medical technologies, increasing customizable facilities, improving quality and efficacy of CGT supply chain services, and novel supply chain service innovations by pharmaceutical companies enhance the market growth. However, the high investment cost required for CGT supply chain services, lack of standard therapy protocols, and complex procedures hinder the market growth.
Segmentation of Cell and Gene Therapy Supply Chain/Logistics market includes Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), Mode of Deployment (Cloud-based solution, On-premises solution), End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization). Regionally, the Cell and Gene Therapy Supply Chain/Logistics market can be divided into North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa. North America, followed by Europe, holds the maximum share of this market due to increased research and development expenditure, improved CGT supply chain services efficiency, and the fast adoption of advanced technologies.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 1.5 Billion |
| Revenue Forecast In 2034 | USD 4.4 Billion |
| Growth Rate CAGR | CAGR of 11.9 % from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Application area, Type of software solution, Mode of Deployment, End-user, Scale of operation |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Be The Match BioTherapies, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Lykan Bioscience, Clarkston Consulting, SAP, Hypertrust Patient Data Care, Haemonetics, MasterControl, TraceLink, SAVSU Technologies, TrakCel, Title21 Health Solutions, sedApta Group, Vineti, Stafa Cellular Therapy, Thermo Fisher Scientific(Patheon), McKesson, Biocair, Marken(UPS Company), Modality Solutions, Almac, Arvato Supply Chain Solutions SE, Catalent, Inc, BioLife Solutions, Inc, Biostor Ltd, Yourway Biopharma Services Company, Atelerix Ltd |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy Supply Chain/Logistics Market Snapshot
Chapter 4. Global Cell and Gene Therapy Supply Chain/Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Application Area Estimates & Trend Analysis
5.1. By Applications & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Application Area:
5.2.1. Donor eligibility assessment
5.2.2. Sample collection
5.2.3. Manufacturing
5.2.4. Logistics
5.2.5. Patient verification and treatment follow-up
Chapter 6. Market Segmentation 1: By Type of Software Solution Estimates & Trend Analysis
6.1. By Software Solution & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Type of Software Solution:
6.2.1. Cell orchestration platform
6.2.2. Enterprise manufacturing system
6.2.3. Inventory management system
6.2.4. Laboratory information management system
6.2.5. Logistics management system
6.2.6. Patient management system
6.2.7. Quality management system
6.2.8. Tracking and tracing system
Chapter 7. Market Segmentation 1: By End-User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By End-User:
7.2.1. Biobank
7.2.2. Cell Therapy Lab
7.2.3. Hospital
7.2.4. Research Institute
7.2.5. Commercial Organization
Chapter 8. Market Segmentation 2: By Mode of Deployment Estimates & Trend Analysis
8.1. By Mode of Deployment & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Mode of Deployment:
8.2.1. Cloud
8.2.2. On-premises
Chapter 9. Cell and Gene Therapy Supply Chain/Logistics Market Segmentation 3: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.1.2. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.1.3. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.4. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.1.5. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.2.2. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.2.3. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034
9.2.4. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.2.5. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.3.2. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.3.3. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034
9.3.4. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.3.5. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.4.2. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.4.3. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.4.4. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.4.5. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.5.2. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.5.3. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.5.4. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.5.5. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Be The Match BioTherapies
10.2.2. MAK-SYSTEM
10.2.3. Cryoport
10.2.4. Brooks Life Sciences
10.2.5. Lykan Bioscience
10.2.6. Clarkston Consulting
10.2.7. SAP
10.2.8. Hypertrust Patient Data Care
10.2.9. Haemonetics
10.2.10. MasterControl
10.2.11. TraceLink
10.2.12. SAVSU Technologies
10.2.13. TrakCel
10.2.14. Title21 Health Solutions
10.2.15. sedApta Group
10.2.16. Vineti
10.2.17. Stafa Cellular Therapy
10.2.18. Thermo Fisher Scientific(Patheon)
10.2.19. McKesson
10.2.20. Biocair
10.2.21. Marken(UPS Company)
10.2.22. Modality Solutions
10.2.23. Almac
10.2.24. Arvato Supply Chain Solutions SE
10.2.25. Catalent, Inc
10.2.26. BioLife Solutions, Inc
10.2.27. Biostor Ltd
10.2.28. Yourway Biopharma Services Company
10.2.29. Atelerix Ltd
10.2.30. Other Prominent Players
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Application Area
· Donor & Patient Enrollment
· Sample Collection & Processing
· Manufacturing & Quality Operations
· Cryogenic Logistics & Distribution
· Patient Administration & Follow-Up
· Data Integration & Regulatory Compliance
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Type of Software Solution
· Cell Orchestration Platforms (COI/COC)
· Manufacturing Execution Systems (MES)
· Inventory & Material Management Systems
· Laboratory Information Management Systems (LIMS)
· Logistics & Supply Chain Management Platforms
· Patient & Donor Management Systems
· Quality & Compliance Management Systems (QMS)
· Tracking, Traceability & Analytics Platforms
· Integrated Data / Interoperability Layers
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on End-User
· Biobanks & Repository Operators
· Cell Therapy Manufacturing Facilities
· Hospitals & Transplant Centers
· Research Institutes / Academic Medical Centers
· Biopharma & CGT Developers
· CDMOs / CROs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Scale of Operation
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Type of Deployment
· Cloud-Based
· On-Premises
· Hybrid
· SaaS Subscription
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Region
North America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
Europe Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
Asia Pacific Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
Latin America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
Competitive Landscape